Allianz Asset Management Gmb H Gilead Sciences, Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 4,325,555 shares of GILD stock, worth $404 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

4,325,555

Previous 4,218,489 2.54%

Holding current value

$404 Million

Previous $289 Million 25.27%

% of portfolio

0.52%

Previous 0.44%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $7.13 Million - $8.99 Million	107,066 Added 2.54%	4,325,555 $363 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $6 Million - $6.93 Million	-95,091 Reduced 2.2%	4,218,489 $289 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $6.38 Million - $7.78 Million	89,105 Added 2.11%	4,313,580 $316 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $18.2 Million - $20.7 Million	248,618 Added 6.25%	4,224,475 $342 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $17.6 Million - $19.2 Million	237,498 Added 6.35%	3,975,857 $298 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $42.9 Million - $49 Million	564,888 Added 17.8%	3,738,359 $288 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $10.7 Million - $12.2 Million	138,997 Added 4.58%	3,173,471 $263 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $40.5 Million - $58.1 Million	-649,647 Reduced 17.63%	3,034,474 $261 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $17.6 Million - $20.1 Million	-295,680 Reduced 7.43%	3,684,121 $227 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.98 Million - $3.36 Million	-51,620 Reduced 1.28%	3,979,801 $246 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $8.55 Million - $10.7 Million	-147,695 Reduced 3.53%	4,031,421 $240 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $13.3 Million - $15.2 Million	-205,749 Reduced 4.69%	4,179,116 $304 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $219 Million - $237 Million	3,242,180 Added 283.73%	4,384,865 $306 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $19.8 Million - $21.7 Million	-312,188 Reduced 21.46%	1,142,685 $78.7 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $8.63 Million - $9.85 Million	143,830 Added 10.97%	1,454,873 $94 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $12.6 Million - $14.4 Million	222,317 Added 20.42%	1,311,043 $76.4 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $94.3 Million - $119 Million	-1,518,823 Reduced 58.25%	1,088,726 $68.8 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $61.1 Million - $71 Million	-844,813 Reduced 24.47%	2,607,549 $201 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $12 Million - $15.4 Million	-191,630 Reduced 5.26%	3,452,362 $258 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $2.74 Million - $3.01 Million	-44,395 Reduced 1.2%	3,643,992 $237 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $42 Million - $46.3 Million	-671,394 Reduced 15.4%	3,688,387 $234 Million
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $12.4 Million - $14 Million	-201,207 Reduced 4.41%	4,359,781 $295 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $13.9 Million - $15.6 Million	-222,895 Reduced 4.66%	4,560,988 $297 Million
Q4 2018 Apr 02, 2019	SELL	$60.54 - $79.0 $3.95 Million - $5.15 Million	-65,221 Reduced 1.35%	4,783,883 $299 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $19 Million - $24.8 Million	314,361 Added 6.93%	4,849,104 $303 Million
Q3 2018 Apr 09, 2019	SELL	$71.28 - $78.92 $3.36 Million - $3.72 Million	-47,093 Reduced 1.03%	4,534,743 $350 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $46.5 Million - $51.5 Million	652,939 Added 16.62%	4,581,836 $354 Million
Q2 2018 Apr 09, 2019	SELL	$64.88 - $75.68 $2.34 Million - $2.73 Million	-36,070 Reduced 0.91%	3,928,897 $278 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $26.7 Million - $31.2 Million	-412,109 Reduced 9.42%	3,964,967 $281 Million
Q1 2018 Apr 09, 2019	SELL	$72.84 - $88.8 $1.35 Million - $1.65 Million	-18,543 Reduced 0.42%	4,377,076 $330 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $52.1 Million - $63.5 Million	-714,625 Reduced 13.98%	4,395,619 $331 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $42.5 Million - $49.9 Million	597,615 Added 13.24%	5,110,244 $366 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $33.6 Million - $39.8 Million	466,059 Added 11.52%	4,512,629 $366 Million
Q2 2017 Aug 14, 2017	BUY	N/A	420,400 Added 11.59%	4,046,570 $287 Million
Q1 2017 Apr 17, 2019	SELL	N/A	-1,054,219 Reduced 22.52%	3,626,170 $246 Million
Q4 2016 Apr 17, 2019	BUY	N/A	338,408 Added 7.79%	4,680,389 $335 Million
Q3 2016 Apr 17, 2019	BUY	N/A	4,341,981	4,341,981 $342 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Gilead Sciences, Inc. Transaction History